WealthShield Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.2K | Sell |
774
-900
| -54% | -$74.6K | 0.01% | 415 |
|
|
2025
Q1 | $136K | Sell |
1,674
-194
| -10% | -$15.7K | 0.02% | 344 |
|
|
2024
Q4 | $168K | Sell |
1,868
-235
| -11% | -$21.2K | 0.02% | 298 |
|
|
2024
Q3 | $208K | Buy |
2,103
+78
| +4% | +$7.71K | 0.03% | 291 |
|
|
2024
Q2 | $188K | Buy |
2,025
+772
| +62% | +$71.6K | 0.03% | 282 |
|
|
2024
Q1 | $119K | Sell |
1,253
-701
| -36% | -$66.5K | 0.02% | 307 |
|
|
2023
Q4 | $174K | Sell |
1,954
-250
| -11% | -$22.3K | 0.03% | 286 |
|
|
2023
Q3 | $161K | Hold |
2,204
| – | – | 0.02% | 306 |
|
|
2023
Q2 | $183K | Hold |
2,204
| – | – | 0.03% | 300 |
|
|
2023
Q1 | $168K | Sell |
2,204
-8,000
| -78% | -$610K | 0.03% | 300 |
|
|
2022
Q4 | $847K | Buy |
10,204
+116
| +1% | +$9.63K | 0.16% | 152 |
|
|
2022
Q3 | $800K | Buy |
+10,088
| New | +$800K | 0.16% | 150 |
|
|
2022
Q1 | – | Sell |
-2,817
| Closed | -$315K | – | 374 |
|
|
2021
Q4 | $315K | Buy |
+2,817
| New | +$315K | 0.05% | 227 |
|
|
2021
Q3 | – | Sell |
-200
| Closed | -$27K | – | 761 |
|
|
2021
Q2 | $27K | Sell |
200
-21,876
| -99% | -$2.95M | ﹤0.01% | 609 |
|
|
2021
Q1 | $3M | Sell |
22,076
-26,269
| -54% | -$3.56M | 0.54% | 55 |
|
|
2020
Q4 | $6.81M | Buy |
48,345
+42,358
| +707% | +$5.96M | 1.26% | 20 |
|
|
2020
Q3 | $667K | Sell |
5,987
-870
| -13% | -$96.9K | 0.23% | 97 |
|
|
2020
Q2 | $768K | Buy |
+6,857
| New | +$768K | 0.35% | 62 |
|
|
2020
Q1 | – | Sell |
-675
| Closed | -$64K | – | 308 |
|
|
2019
Q4 | $64K | Buy |
+675
| New | +$64K | 0.03% | 207 |
|
|
2018
Q4 | – | Sell |
-2,716
| Closed | -$260K | – | 290 |
|
|
2018
Q3 | $260K | Hold |
2,716
| – | – | 0.15% | 106 |
|
|
2018
Q2 | $259K | Buy |
+2,716
| New | +$259K | 0.16% | 100 |
|